Black Diamond Therapeutics, Inc. (BDTX)
1.81
+0.06
(+3.43%)
USD |
NASDAQ |
Nov 03, 16:00
1.805
0.00 (0.00%)
After-Hours: 20:00
Black Diamond Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2025 | 99.88% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Lineage Cell Therapeutics, Inc. | 82.51% |
| Armata Pharmaceuticals, Inc. | 76.45% |
| Voyager Therapeutics, Inc. | 71.31% |
| Invivyd, Inc. | 86.62% |
| Elicio Therapeutics, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -37.24% |
| Return on Assets | -29.35% |
| Return on Invested Capital | -31.98% |
| Return on Net Operating Assets | -333.8% |